Proteomics utilizes a comprehensive set of technologies to detect, quantify and characterize proteins to assess normal biology and perturbations that cause diseases. Research clinicians wish to access leverage the analytical power of proteomics (and LCMS in general) to better understand disease and potentially provide better therapeutic solutions in medical care, but are generally not formally trained in LCMS technology.
Lorne Taylor, Manager of the Clinical Proteomics Platform (serves 5 separate on-site hospitals with over 2,100 research staff and 550 researchers) at the Research Institute of the McGill University Health Center (RI-MUHC) in Montreal serves as the bridge between the research bench and the research clinicians.
In this webinar he will show how combining small molecule quantitation with proteomics helps research clinicians to get a better picture of the biomolecular flux and changes in wellness and disease.
For research use only. Not for use in diagnostic procedures.
